Chromium Picolinate Improves Insulin Sensitivity In Obese Subjects With Polycystic Ovary Syndrome
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 5 |
| 性別 | 女性 |
| 年齢 | 18-29 |
| 体型 | 肥満 |
この研究の注釈：
In five women with PCOS, supplementation of 470mcg chromium (as picolinate) twice daily for two months appeared to improve insulin sensitivity as assessed by glucose disposal rates, but no other parameter was significantly improved; insulin was nonsignificantly reduced.
The Effects Of Chromium Supplementation On Endocrine Profiles, Biomarkers Of Inflammation, And Oxidative Stress In Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
| 効果 | なし |
| 数値 | Difference between groups: 0.4 ± 11.4 IU/L. P = 0.87. |
| 試験方法 | ランダム化比較試験 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 60 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
この研究の注釈：
60 woman with PCOS were given either placebo or 200 µg chromium picolinate for 8 weeks. Chromium reduced acne, hirsutism, and C-reactive protein and improved plasma total antioxidant capacity but no change in reproductive hormones (FSH, LH, prolactin, and free testosterone).